Company intelligence / Profile preview

Denti.AI

Toronto, Ontario, Canadadenti.ai ↗

Ownership: Private
Employees: ~51
Development stage: Commercial

Overview

Denti.AI has received FDA 510(k) clearance for its AI-powered solutions—Denti.AI Detect and Auto‑Chart—which automate the detection of key dental pathologies from x-rays and streamline odontogram charting. Clinical studies show a 26% increase in treatment opportunities identified by dentists using their platform. The company’s technology is integrated with major practice management systems across North America, supporting hundreds of active users

Therapeutic areas: Other
Modalities: DeviceSoftware
Industry: Medical Imaging

Partnerships

P&R Dental Strategies (strategic artificial intelligence partnership)

Beyond the preview

Go deeper on Denti.AI.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Denti.AI.

Explore the full profile